Morgan Stanley initiated coverage of Palantir Technologies Inc. (NYSE:PLTR) with an underweight rating and $60 price target ...
Boston Scientific stock popped Wednesday after the medtech giant agreed to full acquire Bolt Medical for up to $900 million.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback